Patient Care

bridging the gap
Patient Care

HHS’s New Rules on Interoperability and Patient Access

By Kevin Fleming Just last week, two departments within the U.S. Department of Health and Human Services (HHS) proposed new rules that recognize an important and accelerating dynamic in the healthcare industry, patient consumerism. These rules were designed to further the industry’s transition into a modern, consumer-driven operating model. Though […]

chop logo
Patient Care

Children’s Hospital of Philadelphia Expands Community Asthma Prevention Program

Children’s Hospital of Philadelphia (CHOP), in partnership with the Philadelphia Housing Development Corporation (PHDC), announced a new Community Asthma Prevention Program Plus (CAPP+) Home Repairs Program, developed to address the impact of unhealthy housing on pediatric asthma outcomes in West Philadelphia neighborhoods. CAPP+ is the pilot initiative of Healthier Together, […]

Patient Care

Historic UN High-Level Meeting on TB

The UN High-Level Meeting (HLM) on Tuberculosis will take place today at the United Nations in New York. This will be the UN General Assembly’s first-ever meeting to accelerate efforts against this disease. The ATS calls on all countries, including the United States, to commit to ending TB at this […]

Patient Care

New Guideline Aids in Diagnosing Idiopathic Pulmonary Fibrosis

A new international guideline has been developed to help physicians diagnosis idiopathic pulmonary fibrosis (IPF), a rare and often fatal lung disease whose cause is unknown. The 2018 clinical practice guideline was developed by experts representing four major respiratory societies—the American Thoracic Society (ATS), the European Respiratory Society (ERS), Japanese […]

best and worst states for healthcare
Patient Care

2018’s Best & Worst States for Health Care

With the Affordable Care Act remaining in effect and the CDC reporting that over 88 percent of the population has a regular place to go for medical care, the personal-finance website WalletHub today released its report on 2018’s Best & Worst States for Health Care as well as accompanying videos. In order to […]

orkambi for cystic fibrosis
Patient Care Respiratory

FDA Approves ORKAMBI®, First Medicine to Treat the Underlying Cause of CF for Children Ages 2-5 Years with Most Common Form of the Disease

Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration (FDA) has approved ORKAMBI® (lumacaftor/ivacaftor) to include use in children ages 2 through 5 years with cystic fibrosis (CF) who have two copies of the F508del-CFTR mutation, making it the first medicine approved to treat the underlying cause of CF […]